EGRP News Flash - March 3, 2012
Reissuance of Program Announcements for Small Business Innovation Research and Small Business Technology Transfer Grant Applications
The National Institutes of Health (NIH) reissued two Program Announcements (PAs) for Small Business Innovation Research (SBIR) and Small Business Technology Transfer (STTR) grant applications. The SBIR and STTR Programs are the National Cancer Institute's (NCI) engine of innovation for developing and commercializing novel technologies and products to prevent, detect, diagnose, and treat cancer while enhancing cancer research and control.
The research topics shown in the SBIR and STTR PAs represent program areas that may be of interest to applicant small business concerns in the development of projects that have potential for commercialization. NCI's SBIR and STTR Programs offer funding for research including, but not limited to, cancer control, epidemiology, e-Health, cancer prevention, cancer biology, imaging, in vitro diagnostics, and therapeutic agents and devices.
Generally, NCI does not fund Phase I applications greater than $300,000 total costs or project periods greater than two years. For Phase II applications, NCI does not generally fund applications greater than $2,000,000 total costs or project periods greater than three years. Applicants are encouraged to propose a budget that is reasonable and appropriate for completion of the research project. View more Institute-specific information.
The 2012 application submission dates are April 5, August 5, and December 5. Submission dates for AIDS/AIDS-related research are May 7 and September 7, 2012 and January 7, 2013.
For general questions about cancer epidemiology topics, contact Mukesh Verma, Ph.D., Chief, Methods and Technologies Branch.
Access the NIH GUIDE FOR GRANTS AND CONTRACTS for details: